ProCE Banner Activity

ExpressPoints: Using Available Evidence and Guidelines for Managing an Evolving AML Treatment Paradigm

Slideset

Download this short summary slideset of key takeaways from a CCO Live Webinar for curated overview of current guidelines and optimal treatment of patients with AML in the clinic today.

Released: December 17, 2020

Expiration: December 16, 2021

Share

Faculty

Amir Fathi

Amir Fathi, MD

Assistant Professor of Medicine
Department of Medicine
Harvard Medical School
Division of Hematology/Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Alice Mims

Alice Mims, MD, MSCR

Associate Professor
Division of Hematology
Department of Internal Medicine
The Ohio State University
Columbus, Ohio

Farhad Ravandi

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Agios Pharmaceuticals

Jazz Pharmaceuticals, Inc.

Pfizer, Inc.

Faculty Disclosure

Primary Author

Amir Fathi, MD

Assistant Professor of Medicine
Department of Medicine
Harvard Medical School
Division of Hematology/Oncology
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Alice Mims, MD, MSCR

Associate Professor
Division of Hematology
Department of Internal Medicine
The Ohio State University
Columbus, Ohio

Farhad Ravandi, MD

Professor of Medicine
Department of Leukemia
University of Texas M. D. Anderson Cancer Center
Houston, Texas